Clinical Trial Update: PRO 140 for Human Immunodeficiency Virus [Phase 2]

View source ↗

Summary

A Phase 2 trial of PRO 140 (leronlimab) for HIV sponsored by Drexel University has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PRO 140 (leronlimab)

Snippet

Sponsor: Drexel University | Conditions: HIV | Phase 2 | Status: WITHDRAWN